Price T Rowe Associates Inc Nuvation Bio Inc. Transaction History

Price T Rowe Associates Inc

  • $836 Billion
  • Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 220,319 shares of NUVB stock, worth $515,546. This represents 0.0% of its overall portfolio holdings.

Number of Shares
220,319
Previous 1,354,632 83.74%
Holding current value
$515,546
Previous $4.93 Million 86.94%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$2.58 - $3.69 $2.93 Million - $4.19 Million
-1,134,313 Reduced 83.74%
220,319 $644,000
Q1 2024

May 15, 2024
BUY
$1.46 - $3.97 $1.67 Million - $4.55 Million
1,146,794 Added 551.77%
1,354,632 $4.93 Million
Q4 2023

Feb 14, 2024
SELL
$0.96 - $1.53 $560,710 - $893,631
-584,073 Reduced 73.75%
207,838 $314,000
Q3 2023

Nov 14, 2023
SELL
$1.26 - $2.1 $17,524 - $29,206
-13,908 Reduced 1.73%
791,911 $1.06 Million
Q2 2023

Aug 14, 2023
SELL
$1.56 - $1.84 $76,202 - $89,880
-48,848 Reduced 5.72%
805,819 $1.45 Million
Q1 2023

May 15, 2023
SELL
$1.6 - $2.48 $32,272 - $50,021
-20,170 Reduced 2.31%
854,667 $1.42 Million
Q4 2022

Feb 14, 2023
SELL
$1.68 - $2.5 $61,649 - $91,740
-36,696 Reduced 4.03%
874,837 $1.68 Million
Q3 2022

Nov 14, 2022
BUY
$0.29 - $4.04 $239,663 - $3.34 Million
826,426 Added 971.04%
911,533 $2.04 Million
Q2 2022

Aug 15, 2022
BUY
$3.24 - $5.85 $112,275 - $202,720
34,653 Added 68.68%
85,107 $276,000
Q1 2022

May 16, 2022
BUY
$4.6 - $8.83 $60,775 - $116,661
13,212 Added 35.48%
50,454 $265,000
Q4 2021

Feb 14, 2022
BUY
$7.75 - $10.05 $179,536 - $232,818
23,166 Added 164.58%
37,242 $317,000
Q3 2021

Nov 15, 2021
BUY
$7.78 - $10.0 $20,173 - $25,930
2,593 Added 22.58%
14,076 $140,000
Q2 2021

Aug 16, 2021
BUY
$9.22 - $14.48 $105,873 - $166,273
11,483 New
11,483 $107,000

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $508M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email